Water Sports |
|
|
Clinical Trial: Bladder Cancer Case Control Study of Arsenic in Water
This study is currently recruiting patients.
|
Purpose
This study is examining the relationship between ingested arsenic and bladder cancer in two areas of California where a large percentage of the population was exposed to drinking water containing arsenic at low to moderate levels.
| Condition |
|---|
| Bladder Cancer |
MedlinePlus related topics: Bladder Cancer
Genetics Home Reference related topics: bladder cancer
Study Type: Observational
Study Design: Natural History, Longitudinal, Case Control, Retrospective Study
Expected Total Enrollment: 600
Study start: October 1997; Expected completion: July 2001
Water supplies in many parts of the world contain naturally occurring arsenic. Previous studies have shown that arsenic at high doses can cause cancer of the bladder. The risk at lower doses is unknown. This study is examining the relationship between ingested arsenic and bladder cancer in central Nevada and Kings County, California, two areas where a large percentage of the population was exposed to drinking water containing arsenic at low to moderate levels. Approximately 200 people with bladder cancer and 400 people without bladder cancer will be included. Subjects are interviewed by telephone about past residences, occupations, diet, drinking water consumption, and other lifestyle factors. Arsenic measurements in well water have been collected from the appropriate state agencies and are being matched with residences and drinking water consumption rates to estimate lifetime arsenic exposures for each subject. People with bladder cancer will then be compared to those without to see if people with cancer were more likely to have lived in areas with arsenic in their drinking water.
Eligibility
Ages Eligible for Study: 20 Years - 85 Years, Genders Eligible for Study: Both
Accepts Healthy Volunteers
Criteria
Cases must meet the following criteria:
-Diagnosed with primary bladder cancer from January 1, 1997 until December 31, 2000.
-Live in the following counties at the time of diagnosis: Churchill, Lyon, Mineral, Storey, Douglas, Carson City, Nevada, and Kings County, California
-Ages 20-85 at the time of diagnosis.
Controls will be matched to cases based on gender and five year age groups.
Location and Contact Information
California
Allan Smith Research Office, Berkeley, California, 94720, United States; Recruiting
Allan H Smith, MD, PhD, Principal Investigator
More Information
Record last reviewed: August 2000
Last Updated: October 13, 2004
Record first received: February 22, 2001
ClinicalTrials.gov Identifier: NCT00011518
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 8, 2005

Not Signed In -


